(Q36567407)

15 August 2017

1 reference

title

An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice (English)

1 reference

15 August 2017

0 references

Leeming DJ

1

1 reference

15 August 2017

Alexandersen P

2

1 reference

15 August 2017

Karsdal MA

3

1 reference

15 August 2017

Qvist P

4

1 reference

15 August 2017

Schaller S

5

1 reference

15 August 2017

Tankó LB

6

1 reference

15 August 2017

16 August 2006

1 reference

European Journal of Clinical Pharmacology

15 August 2017

1 reference

15 August 2017

62

1 reference

15 August 2017

10

1 reference

15 August 2017

781-792

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-006-0174-3

15 August 2017

0 references

cites work

Prediction of bone loss in postmenopausal women

1 reference

12 December 2020

Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women

1 reference

12 December 2020

Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures

1 reference

12 December 2020

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

12 December 2020

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate

1 reference

12 December 2020

Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

1 reference

12 December 2020

Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis

1 reference

12 December 2020

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

1 reference

12 December 2020

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment

1 reference

12 December 2020

A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover

1 reference

12 December 2020

Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region

1 reference

12 December 2020

Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group

1 reference

12 December 2020

The future of osteoporosis diagnosis and therapy

1 reference

12 December 2020

The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

1 reference

12 December 2020

Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women

1 reference

12 December 2020

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

1 reference

12 December 2020

Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.

1 reference

12 December 2020

Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism

1 reference

12 December 2020

Biochemical predictors for osteoporotic fractures in elderly Chinese--a longitudinal study

1 reference

12 December 2020

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

1 reference

12 December 2020

The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation

1 reference

12 December 2020

Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation

1 reference

12 December 2020

Efficacy and safety of ibandronate given by intravenous injection once every 3 months

1 reference

12 December 2020

Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.

1 reference

12 December 2020

Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women.

1 reference

12 December 2020

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

1 reference

12 December 2020

Minireview: the OPG/RANKL/RANK system

1 reference

12 December 2020

Is the paradigm shifting?

1 reference

12 December 2020

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density

1 reference

12 December 2020

Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment

1 reference

12 December 2020

In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?

1 reference

12 December 2020

Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase

1 reference

12 December 2020

Correlates of osteoprotegerin levels in women and men.

1 reference

12 December 2020

Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study

1 reference

12 December 2020

Biochemical markers of bone turnover

1 reference

12 December 2020

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

1 reference

12 December 2020

Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study.

1 reference

12 December 2020

Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women

1 reference

12 December 2020

Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens

1 reference

12 December 2020

An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.

1 reference

12 December 2020

Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers

1 reference

12 December 2020

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption.

1 reference

12 December 2020

Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women

1 reference

12 December 2020

7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.

1 reference

12 December 2020

Identification of osteopenic women at high risk of fracture: the OFELY study.

1 reference

12 December 2020

Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy

1 reference

12 December 2020

Tibolone: prevention of bone loss in late postmenopausal women

1 reference

12 December 2020

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial

1 reference

12 December 2020

1 reference

12 December 2020

Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures?

1 reference

12 December 2020

Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study

1 reference

12 December 2020

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

1 reference

12 December 2020

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

1 reference

12 December 2020

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

12 December 2020

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

1 reference

12 December 2020

Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

1 reference

12 December 2020

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation

1 reference

12 December 2020

Clinical utility of biochemical markers of bone remodeling

1 reference

12 December 2020

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women.

1 reference

12 December 2020

Inverse association between bone turnover rate and bone mineral density in community-dwelling men >70 years of age: no major role of sex steroid status

1 reference

12 December 2020

Sandwich enzyme immunoassay of osteocalcin in serum with use of an antibody against human osteocalcin

1 reference

12 December 2020

Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K

1 reference

12 December 2020

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

12 December 2020

Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.

1 reference

12 December 2020

The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy

1 reference

12 December 2020

Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.

1 reference

12 December 2020

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

1 reference

12 December 2020

Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).

1 reference

12 December 2020

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study

1 reference

12 December 2020

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial

1 reference

12 December 2020

The OPG/RANKL/RANK system in metabolic bone diseases.

1 reference

12 December 2020

Circadian variation in bone resorption is not related to serum cortisol

1 reference

12 December 2020

Predictive Value of BMD for Hip and Other Fractures

1 reference

12 December 2020

Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

1 reference

12 December 2020

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

12 December 2020

Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by CAPD

1 reference

12 December 2020

Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis

1 reference

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

12 December 2020

Prevention of spinal osteoporosis in oophorectomised women

1 reference

12 December 2020

Genetic regulation of osteoclast development and function

1 reference

12 December 2020

Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

12 December 2020

Two-site enzyme immunoassay for measuring intact human osteocalcin in serum

1 reference

12 December 2020

Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study

1 reference

12 December 2020

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study

1 reference

12 December 2020

Male osteoporosis: epidemiology and pathophysiology

1 reference

12 December 2020

Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.

1 reference

12 December 2020

Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover

1 reference

12 December 2020

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology

1 reference

12 December 2020

A simple enzyme-linked immunosorbent assay of human osteocalcin

1 reference

12 December 2020

Relationship of bone turnover to bone density and fractures

1 reference

12 December 2020

10.1007/S00228-006-0174-3

Identifiers

DOI

1 reference

15 August 2017

1 reference